Syneos Health Executive and Leadership Team

Costa Panagos, the Chief Executive Officer at Syneos Health, directs the overarching corporate strategy for this global biopharmaceutical research organization. Panagos oversees the integration of clinical and commercial services to ensure therapies reach patients with maximum efficiency. By aligning internal resources with the evolving needs of pharmaceutical and biotechnology clients, the Chief Executive Officer drives sustainable growth across international markets. This leadership role involves constant collaboration with the Board to refine the long-term vision for the company. Costa Panagos maintains a focus on leveraging data-driven insights to address complex healthcare challenges. Through the implementation of advanced technologies, the Chief Executive Officer optimizes operational performance across the Americas, Europe, and Asia Pacific. Ultimately, Panagos secures the competitive position of the firm within the global life sciences industry while fostering a culture of innovation and excellence.

Phil Deschamps, the President And Chief Executive Officer, Gsw Worldwide at Syneos Health, manages the specialized commercial and marketing strategy divisions. Deschamps architects creative solutions that translate complex clinical data into compelling narratives for healthcare providers and patients. Overseeing the global creative agency footprint, the President And Chief Executive Officer, Gsw Worldwide ensures that brand messaging aligns with the broader commercial goals of the organization. This role requires deep engagement with biotechnology partners to accelerate market adoption of new therapies. Phil Deschamps drives the development of digital-first marketing campaigns that span diverse geographic regions. By integrating medical affairs expertise with commercial strategy, the President And Chief Executive Officer, Gsw Worldwide enhances the impact of client portfolios. Through consistent focus on market differentiation, Deschamps strengthens the reputation of the firm as a leader in biopharmaceutical commercialization.

Michael Bonello, the Chief Financial Officer at Syneos Health, manages the financial health and fiscal strategy of the organization. Bonello oversees capital allocation, financial reporting, and long-term investment planning to support the global expansion of research services. By analyzing market trends and operational costs, the Chief Financial Officer ensures that the company maintains a robust balance sheet while funding innovation in clinical trials. This role involves close coordination with the executive team to align financial goals with strategic business objectives. Michael Bonello drives the implementation of financial controls that enhance transparency and accountability across all international operations. Through rigorous oversight of fiscal performance, the Chief Financial Officer supports the sustainable growth of the firm. Bonello secures the financial foundation necessary for the company to continue providing high-quality biopharmaceutical development services to clients worldwide.

Alan Birtchet, the Chief Operating Officer, Selling Solutions at Syneos Health, manages the internal infrastructure and delivery models for commercial selling services. Birtchet architects scalable operational frameworks that allow the company to deploy sales teams and commercial resources rapidly for pharmaceutical clients. By focusing on the efficiency of field-based operations, the Chief Operating Officer, Selling Solutions ensures that commercial strategies translate into measurable market impact. This role involves overseeing the logistics of large-scale commercial launches and managing the performance of regional sales forces. Alan Birtchet drives the integration of technology into selling processes to improve data capture and reporting. Through the optimization of operational workflows, the Chief Operating Officer, Selling Solutions enhances the speed and effectiveness of client commercialization efforts. Birtchet maintains a focus on operational excellence to support the firm's position as a premier provider of commercial solutions.

Paul Mignon, the President and Global Head Selling Solutions at Syneos Health, manages the strategic direction and growth of the global commercial selling business. Mignon oversees the expansion of commercial capabilities, ensuring that the company provides comprehensive support for product launches and market access. By identifying emerging market trends, the President and Global Head Selling Solutions architects strategies that help clients maximize the value of their therapeutic assets. This role involves leading large-scale commercial engagements across diverse geographic regions, including the Americas and Europe. Paul Mignon drives the development of innovative selling models that leverage data-driven insights to reach healthcare providers effectively. Through the coordination of global sales teams, the President and Global Head Selling Solutions enhances the market presence of pharmaceutical and biotechnology partners. Mignon secures the long-term success of the commercial division by focusing on client-centric service delivery.

Tara Fitzgerald, the President, Clinical Development Services at Syneos Health, directs the global operations of the clinical research division. Fitzgerald oversees the execution of complex clinical trials, ensuring that all projects adhere to global regulatory standards and timelines. By managing a vast network of clinical sites and research professionals, the President, Clinical Development Services drives the efficient delivery of data that supports the approval of new therapies. This role involves collaborating with biotechnology and pharmaceutical clients to design and implement innovative trial strategies. Tara Fitzgerald monitors the performance of clinical programs across multiple therapeutic areas to ensure high-quality outcomes. Through the application of advanced technology and process optimization, the President, Clinical Development Services enhances the speed of drug development. Fitzgerald secures the operational success of the clinical division, contributing significantly to the overall mission of the firm.

Kevin Funkhouser, the Syneos Operations Chief of Staff at Syneos Health, coordinates the execution of strategic initiatives across the global organization. Funkhouser directs the flow of information between departments to ensure operational alignment with the corporate mission. By managing complex projects and facilitating communication among senior leaders, the Syneos Operations Chief of Staff optimizes internal processes and decision-making workflows. This role involves identifying bottlenecks in service delivery and implementing solutions that improve cross-functional collaboration. Kevin Funkhouser monitors the progress of key performance indicators to ensure that operational goals remain on track. Through the synchronization of resources and talent, the Syneos Operations Chief of Staff enhances the overall agility of the firm. Funkhouser supports the executive team in navigating the challenges of the life sciences industry, ensuring that the company remains responsive to the needs of pharmaceutical and biotechnology partners.

Simon Bartle, the Chief Human Resources Officer at Syneos Health, directs the global talent strategy and organizational development initiatives. Bartle oversees the recruitment, retention, and professional growth of the diverse workforce required to support complex biopharmaceutical research. By fostering a culture of innovation and inclusivity, the Chief Human Resources Officer ensures that the company attracts top-tier scientific and commercial talent. This role involves designing compensation and benefits programs that remain competitive within the global life sciences market. Simon Bartle drives the implementation of leadership development programs that prepare the next generation of executives. Through the alignment of human capital with business objectives, the Chief Human Resources Officer enhances the overall productivity and engagement of the organization. Bartle secures the human resources necessary for the firm to maintain its status as a leader in clinical and commercial services.

Gregory Licholai, the Chief Medical Officer at Syneos Health, provides clinical leadership and medical expertise across the entire research and development portfolio. Licholai directs the medical strategy for clinical trials, ensuring that all studies meet the highest standards of safety and scientific rigor. By advising on the design of complex protocols, the Chief Medical Officer helps clients navigate the regulatory landscape and accelerate the path to market for new therapies. This role involves collaborating with global medical teams to interpret clinical data and provide actionable insights for pharmaceutical partners. Gregory Licholai drives the integration of medical affairs into the broader commercial strategy of the firm. Through the application of deep clinical knowledge, the Chief Medical Officer enhances the quality of patient outcomes. Licholai ensures that the company remains at the forefront of medical innovation within the life sciences industry.

Lynn Dinsmore, the Managing Director at Syneos Health, oversees regional business operations and client engagement strategies. Dinsmore directs the execution of clinical research projects, ensuring adherence to rigorous quality standards and regulatory requirements. By managing cross-functional teams, the Managing Director facilitates the seamless delivery of integrated services to pharmaceutical clients. This leadership position involves identifying opportunities for operational improvement and scaling service offerings to meet specific market demands. Lynn Dinsmore coordinates with global leadership to ensure that regional initiatives support the overarching mission of the company. Through the application of specialized consulting expertise, the Managing Director optimizes project timelines and resource allocation. Dinsmore maintains a focus on driving efficiency within the clinical development lifecycle, ultimately contributing to the faster delivery of life-saving therapies to patients across the global landscape.